MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 336 participants.

Also called NCT01307046

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 336 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01307046
Other papers using this trial's data
  • Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials Hypertension research : official journal of the Japanese Society of Hypertension, 2014-12 DOI, PubMed 24990091

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01307046. Randomized; double masking; primary purpose treatment. Start 2011-03-29 (actual); primary completion 2012-02-07 (actual). Results posted on 2013-03-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)
Condition
Hypertension
Intervention (Drug)
MK-0954A
Intervention (Drug)
Losartan
Intervention (Drug)
Placebo to MK-0954A
Intervention (Drug)
Placebo to losartan 100 mg
Intervention (Drug)
Placebo to losartan 50 mg
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct01307046
Content hash
624a0c4694e996102006a84ed22852551abe83c4fe02258d429e036065e258f4